C07相關技術服務(CRO/CMO/CDMO等)

Emmes Group is a global, full-service CRO with 48 years of expertise in clinical research, supporting public health agencies and biopharma operations across 72+ countries. Our scope spans early to late-phase trials, biometrics, regulatory, and real-world evidence. Veridix, our tech arm, powers this with Advantage eClinical (AEC)—a modern EDC—and Agentic AI platforms that accelerate trials through automation, intelligent workflows, and predictive insights. Together, we deliver a unified, tech-enabled ecosystem that ensures speed, quality, and compliance. Our integrated approach reduces costs, shortens timelines, and improves data integrity—making Emmes and Veridix ideal partners for end-to-end clinical development.

Veridix, the technology arm of Emmes, powers clinical trials with advanced digital platforms. Its flagship product, Advantage eClinical (AEC), is a unified, single sign-on next-generation EDC platform that streamlines study builds and drives real-time operational oversight. AEC features include: Built-in CDISC standardization for up to 80% automated SDTM conversion AI-powered CRF design, edit checks, and mid-study changes Real-time AI-assisted data review and alerts Integrated sample management with full chain-of-custody tracking